1 – Scheme overview

This scheme is designed to assess the performances of different bacterial identification tests and susceptibility tests (determination of resistance mechanisms), but also for some of the investigations to assess urine cytology and bacterial count techniques, as well as the performance of microbiology culture media.

Statistical reports are sent with supporting comments from the expert clinical biologists who coordinate the scheme.

Program Limited to Metropolitan France.

2 – Assessment frequency

Number of investigations per year : 4
Number of control samples per investigation : 2
Number of samples per year : 8 (2 samples for CBEU, 2 samples for urinary cytology and 4 bacterial swabs)

3 – List of tests assessed

• Bacterial identification
• Antibiogram
• Antibiotic susceptibility
• Screening for specific bacteria (group B Streptococcus, toxin-producing Clostridium difficile, multi-resistant bacteria, etc.)
• Cytology: leucocyturia, hematuria on urinary samples (manual and/or automated techniques).

4 – Description of the control samples

Ready to use control samples

5 - Clinical Setting

The surveys include a clinical context (except for the 2 urinary cytology surveys), based on which users are invited to propose an overall interpretation of the results.